Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo

Zmuda, Filip and Malviya, Gaurav and Blair, Adele and Boyd, Marie and Chalmers, Anthony J. and Sutherland, Andrew and Pimlott, Sally L. (2015) Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo. Journal of Medicinal Chemistry, 58 (21). pp. 8683-8693. ISSN 0022-2623 (https://doi.org/10.1021/acs.jmedchem.5b01324)

[thumbnail of Zmuda-etal-JMC-2015-Synthesis-and-evaluation-of-a-radioiodinated-tracer-with-specificity]
Preview
 Text. Filename: Zmuda_etal_JMC_2015_Synthesis_and_evaluation_of_a_radioiodinated_tracer_with_specificity.pdf
Accepted Author Manuscript
Download (918kB)| Preview

Abstract

Interest in nuclear imaging of poly(ADP-ribose) polymerase-1 (PARP-1) has grown in recent years due to the ability of PARP-1 to act as a biomarker for glioblastoma and increased clinical use of PARP-1 inhibitors. This study reports the identification of a lead iodinated analog 5 of the clinical PARP-1 inhibitor olaparib as a potential single-photon emission computed tomography (SPECT) imaging agent. Compound 5 was shown to be a potent PARP-1 inhibitor in cell-free and cellular assays, and it exhibited mouse plasma stability but approximately 3-fold greater intrinsic clearance when compared to olaparib. An (123)I-labeled version of 5 was generated using solid state halogen exchange methodology. Ex vivo biodistribution studies of [(123)I]-5 in mice bearing subcutaneous glioblastoma xenografts revealed that the tracer had the ability to be retained in tumour tissue and bind to PARP-1 with specificity. These findings support further investigations of [(123)I]-5 as a non-invasive PARP-1 SPECT imaging agent.

ORCID iDs

Zmuda, Filip, Malviya, Gaurav, Blair, Adele, Boyd, Marie ORCID logoORCID: https://orcid.org/0000-0003-4120-2218, Chalmers, Anthony J., Sutherland, Andrew and Pimlott, Sally L.;
CORE (COnnecting REpositories)